AAAAAA

   
Results: 1-25 |
Results: 25
Regulation of hematopoiesis through adhesion receptors
Authors: Prosper, F Verfaillie, CM
Citation: F. Prosper et Cm. Verfaillie, Regulation of hematopoiesis through adhesion receptors, J LEUK BIOL, 69(3), 2001, pp. 307-316
Novel therapies for chronic myelogenous leukemia
Authors: Jahagirdar, BN Miller, JS Shet, A Verfaillie, CM
Citation: Bn. Jahagirdar et al., Novel therapies for chronic myelogenous leukemia, EXP HEMATOL, 29(5), 2001, pp. 543-556
Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells
Authors: Reyes, M Lund, T Lenvik, T Aguiar, D Koodie, L Verfaillie, CM
Citation: M. Reyes et al., Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells, BLOOD, 98(9), 2001, pp. 2615-2625
A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector
Authors: Zhao, RC Jiang, YH Verfaillie, CM
Citation: Rc. Zhao et al., A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector, BLOOD, 97(8), 2001, pp. 2406-2412
Umbilical cord blood cells capable of engrafting in primary secondary, andtertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
Authors: Lewis, ID Almeida-Porada, G Du, JB Lemischka, IR Moore, KA Zanjani, ED Verfaillie, CM
Citation: Id. Lewis et al., Umbilical cord blood cells capable of engrafting in primary secondary, andtertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system, BLOOD, 97(11), 2001, pp. 3441-3449
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
Authors: Davies, SM DeFor, TE McGlave, PB Miller, JS Verfaillie, CM Wagner, JE Weisdorf, DJ
Citation: Sm. Davies et al., Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors, AM J MED, 110(5), 2001, pp. 339-346
A novel in vitro model of early human adult B lymphopoiesis that allows proliferation of pro-B cells and differentiation to mature B lymphocytes
Authors: Barker, J Verfaillie, CM
Citation: J. Barker et Cm. Verfaillie, A novel in vitro model of early human adult B lymphopoiesis that allows proliferation of pro-B cells and differentiation to mature B lymphocytes, LEUKEMIA, 14(9), 2000, pp. 1614-1620
Improved retroviral transduction of hematopoietic progenitors by combiningmethods to enhance virus-cell interaction
Authors: Liu, H Hung, Y Wissink, SD Verfaillie, CM
Citation: H. Liu et al., Improved retroviral transduction of hematopoietic progenitors by combiningmethods to enhance virus-cell interaction, LEUKEMIA, 14(2), 2000, pp. 307-311
Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow
Authors: Verfaillie, CM Almeida-Porada, G Wissink, S Zanjani, ED
Citation: Cm. Verfaillie et al., Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow, EXP HEMATOL, 28(9), 2000, pp. 1071-1079
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation
Authors: Lickliter, JD McGlave, PB DeFor, TE Miller, JS Ramsay, NK Verfaillie, CM Burns, LJ Wagner, JE Eastlund, T Dusenbery, K Weisdorf, DJ
Citation: Jd. Lickliter et al., Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation, BONE MAR TR, 26(7), 2000, pp. 723-728
Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse
Authors: Brunstein, CG Hirsch, BA Miller, JS McGlennen, RC Verfaillie, CM McGlave, PB Weisdorf, DJ
Citation: Cg. Brunstein et al., Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse, BONE MAR TR, 26(11), 2000, pp. 1173-1177
Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34(+) cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27(Kip), which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity
Authors: Jiang, YH Zhao, RCH Verfaillie, CM
Citation: Yh. Jiang et al., Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34(+) cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27(Kip), which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity, P NAS US, 97(19), 2000, pp. 10538-10543
Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors
Authors: Jiang, YH Prosper, F Verfaillie, CM
Citation: Yh. Jiang et al., Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors, BLOOD, 95(3), 2000, pp. 846-854
Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates:requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins
Authors: Gupta, P Oegema, TR Brazil, JJ Dudek, AZ Slungaard, A Verfaillie, CM
Citation: P. Gupta et al., Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates:requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins, BLOOD, 95(1), 2000, pp. 147-155
Cell signaling by adhesion receptors in normal and leukemic hematopoiesis
Authors: Verfaillie, CM Jiang, Y Zhao, RCH Prosper, F Bhatia, R
Citation: Cm. Verfaillie et al., Cell signaling by adhesion receptors in normal and leukemic hematopoiesis, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 125-136
ISHAGE Scientific Committee Report - Assays to determine hematopoietic stem cell content in blood or marrow grafts
Authors: Verfaillie, CM Ploemacher, R Di Persio, J Sutherland, R Serke, S Johnsen, H Noga, S Negrin, R
Citation: Cm. Verfaillie et al., ISHAGE Scientific Committee Report - Assays to determine hematopoietic stem cell content in blood or marrow grafts, CYTOTHERAPY, 1(1), 1999, pp. 41-49
Gene therapy for chronic myelogenous leukemia
Authors: Verfaillie, CM McIvor, RS Zhao, RCH
Citation: Cm. Verfaillie et al., Gene therapy for chronic myelogenous leukemia, MOL MED TOD, 5(8), 1999, pp. 359-366
Chronic myelogenous leukemia: From pathogenesis to therapy
Authors: Verfaillie, CM
Citation: Cm. Verfaillie, Chronic myelogenous leukemia: From pathogenesis to therapy, J HEMATOTH, 8(1), 1999, pp. 3-13
Factor(s) secreted by AFT024 fetal liver cells following stimulation with human cytokines are important for human LTC-IC growth
Authors: Punzel, M Gupta, P Roodell, M Mortari, F Verfaillie, CM
Citation: M. Punzel et al., Factor(s) secreted by AFT024 fetal liver cells following stimulation with human cytokines are important for human LTC-IC growth, LEUKEMIA, 13(7), 1999, pp. 1079-1084
The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells
Authors: Punzel, M Moore, KA Lemischka, IR Verfaillie, CM
Citation: M. Punzel et al., The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells, LEUKEMIA, 13(1), 1999, pp. 92-97
Role of abnormal integrin-cytoskeletal interactions in impaired beta 1 integrin function in chronic myelogenous leukemia hematopoietic progenitors
Authors: Bhatia, R Munthe, HA Verfaillie, CM
Citation: R. Bhatia et al., Role of abnormal integrin-cytoskeletal interactions in impaired beta 1 integrin function in chronic myelogenous leukemia hematopoietic progenitors, EXP HEMATOL, 27(9), 1999, pp. 1384-1396
Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis
Authors: Roy, V Verfaillie, CM
Citation: V. Roy et Cm. Verfaillie, Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis, EXP HEMATOL, 27(2), 1999, pp. 302-312
The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro
Authors: Punzel, M Wissink, SD Miller, JS Moore, KA Lemischka, IR Verfaillie, CM
Citation: M. Punzel et al., The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro, BLOOD, 93(11), 1999, pp. 3750-3756
BCR/ABL(-) CD34(+)HLA-DR- progenitor cells in early chronic phase, but notin more advanced phases, of chronic myelogenous leukemia are polyclonal
Authors: Delforge, M Boogaerts, MA McGlave, PB Verfaillie, CM
Citation: M. Delforge et al., BCR/ABL(-) CD34(+)HLA-DR- progenitor cells in early chronic phase, but notin more advanced phases, of chronic myelogenous leukemia are polyclonal, BLOOD, 93(1), 1999, pp. 284-292
Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche
Authors: Gupta, P Oegema, TR Brazil, JJ Dudek, AZ Slungaard, A Verfaillie, CM
Citation: P. Gupta et al., Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche, BLOOD, 92(12), 1998, pp. 4641-4651
Risultati: 1-25 |